These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15470568)

  • 21. Alprazolam as treatment for a case of obsessive-compulsive disorder.
    Tesar GE; Jenike MA
    Am J Psychiatry; 1984 May; 141(5):689-90. PubMed ID: 6143507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
    Pollack MH; Simon NM; Zalta AK; Worthington JJ; Hoge EA; Mick E; Kinrys G; Oppenheimer J
    Biol Psychiatry; 2006 Feb; 59(3):211-5. PubMed ID: 16139813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations for drug therapy in anxiety. Serotoninergic agents to replace benzodiazepines. Drug Administration Office (Sweden) and State Drug Control(Norway)].
    Lakartidningen; 1995 Mar; 92(12):1256-61. PubMed ID: 7707769
    [No Abstract]   [Full Text] [Related]  

  • 24. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S393-8. PubMed ID: 10622685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbid anxiety and depression.
    Pollack MH
    J Clin Psychiatry; 2005; 66 Suppl 8():22-9. PubMed ID: 16336033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New trends in the treatment of anxiety disorders.
    Brawman-Mintzer O; Yonkers KA
    CNS Spectr; 2004 Aug; 9(8 Suppl 7):19-27. PubMed ID: 15303077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Novel treatment strategies for refractory patients with obsessive-compulsive disorder].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2013; 115(9):997-1003. PubMed ID: 24228478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacotherapy of anxiety disorders].
    Philipp M
    Z Arztl Fortbild (Jena); 1995 May; 89(2):147-50. PubMed ID: 7610681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.
    Keck PE; Strawn JR; McElroy SL
    J Clin Psychiatry; 2006; 67 Suppl 1():8-15. PubMed ID: 16426111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supportive psychotherapy, SSRIs, and MDD.
    Hamilton J; Bridge J
    J Am Acad Child Adolesc Psychiatry; 2006 Jan; 45(1):6-7. PubMed ID: 16327576
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
    Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
    J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM; Hirschfeld RM; Ninan PT
    Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Personality disorders].
    Kiriike N
    Ryoikibetsu Shokogun Shirizu; 2003; (38):469-72. PubMed ID: 12877028
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs to Treat Anxiety Disorders and Obsessive Compulsive Disorder (OCD).
    J Psychosoc Nurs Ment Health Serv; 2024 May; 62(5):5-6. PubMed ID: 38709092
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychotropic drugs in general practice].
    Zimmer A
    Praxis (Bern 1994); 2014 Jun; 103(13):763-6. PubMed ID: 24938158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives].
    Javelot H
    Ann Pharm Fr; 2016 Mar; 74(2):93-118. PubMed ID: 26472602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.